Clinical Trial Update: A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ONM100 for intraoperative detection of peritoneal metastases in peritoneal carcinomatosis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Drugs mentioned

• ONM100

Snippet

Sponsor: OncoNano Medicine, Inc. | Conditions: Peritoneal Carcinomatosis | Phase 2 | Status: COMPLETED | Results posted: 2024-11-08